| scholarly article | Q13442814 |
| P2093 | author name string | Donald G Ahearn | |
| Sidney A Crow | |||
| Carolina Mateus | |||
| P2860 | cites work | Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method | Q29547550 |
| International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia | Q30453797 | ||
| Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance | Q30701532 | ||
| Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate | Q33630438 | ||
| Intravascular catheter-associated infections | Q33856119 | ||
| An ATP-driven efflux pump is a novel pathogenicity factor in rice blast disease | Q33890356 | ||
| Biofilm, city of microbes | Q33899018 | ||
| Isogenic strain construction and gene mapping in Candida albicans. | Q33961115 | ||
| Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions | Q33974357 | ||
| Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test | Q33980755 | ||
| Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. | Q33982286 | ||
| Evolution of drug resistance in experimental populations of Candida albicans. | Q33994006 | ||
| Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium | Q34154526 | ||
| Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. | Q34417276 | ||
| Fungal biofilms and drug resistance | Q34540389 | ||
| Candida biofilms and their role in infection | Q35044563 | ||
| Resistance of Candida albicans biofilms to antifungal agents in vitro | Q35118735 | ||
| Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors | Q35127954 | ||
| Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols | Q35164903 | ||
| Rapid flow cytometric susceptibility testing of Candida albicans | Q36546384 | ||
| Adherence of Pseudomonas aeruginosa to hydrophilic contact lenses and other substrata | Q40208421 | ||
| Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms | Q43415980 | ||
| Transcription initiation of genes associated with azole resistance in Candida albicans | Q43892168 | ||
| Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. | Q54037537 | ||
| Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone. | Q54171440 | ||
| Resistance of adhered bacteria to rigid gas permeable contact lens solutions | Q70908914 | ||
| Primary adhesion of Pseudomonas aeruginosa to inanimate surfaces including biomaterials | Q73147770 | ||
| Expression of a chromosomally integrated, single-copy GFP gene in Candida albicans, and its use as a reporter of gene regulation | Q74406516 | ||
| Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones | Q74416153 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida albicans | Q310443 |
| P304 | page(s) | 3358-3366 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole | |
| P478 | volume | 48 |
| Q33987312 | Alternative mating type configurations (a/α versus a/a or α/α) of Candida albicans result in alternative biofilms regulated by different pathways |
| Q28544418 | An automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteins |
| Q43476035 | Anaerobic growth of Candida albicans does not support biofilm formation under similar conditions used for aerobic biofilm |
| Q37692277 | Antifungal drug resistance of oral fungi |
| Q42727133 | Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity |
| Q37392907 | Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates |
| Q26782611 | Candida Biofilms: Development, Architecture, and Resistance |
| Q26778729 | Candida albicans Biofilms and Human Disease |
| Q51129556 | Candida albicans binds to saliva proteins selectively adsorbed to silicone. |
| Q39077924 | Candida albicans biofilms produce antifungal-tolerant persister cells |
| Q36190737 | Candida biofilm: a well-designed protected environment |
| Q30475833 | Candida biofilms: an update |
| Q48163274 | Candida glabrata Biofilms: How Far Have We Come? |
| Q46276738 | Development and regulation of single- and multi-species Candida albicans biofilms |
| Q37156645 | Efflux-mediated antifungal drug resistance. |
| Q35821475 | Fungal biofilm resistance |
| Q38786061 | Future therapies targeted towards eliminating Candida biofilms and associated infections. |
| Q37824380 | Genetic control of Candida albicans biofilm development |
| Q36539594 | Genetics and genomics of Candida albicans biofilm formation |
| Q36302129 | Genome-wide functional analysis in Candida albicans. |
| Q33994260 | Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans |
| Q34045094 | Growth in a biofilm induces a hyperinfectious phenotype in Vibrio cholerae |
| Q37557700 | Human fungal pathogen Candida albicans in the postgenomic era: an overview. |
| Q41595742 | Human serum potentiates the expression of genes associated with antifungal drug resistance in C. albicans biofilms on central venous catheters |
| Q35076919 | Inhibition of nucleic acid biosynthesis makes little difference to formation of amphotericin B-tolerant persisters in Candida albicans biofilm |
| Q38515541 | Learning the ABC of oral fungal drug resistance. |
| Q52362285 | Nanotechnology-based drug delivery systems for control of microbial biofilms: a review. |
| Q37622959 | Our current understanding of fungal biofilms |
| Q38767464 | Pathogenesis of Candida albicans biofilm |
| Q36114466 | Pseudomonas aeruginosa, Candida albicans, and device-related nosocomial infections: implications, trends, and potential approaches for control |
| Q38131290 | Recent insights into Candida albicans biofilm resistance mechanisms |
| Q34190284 | Regulatory circuitry governing fungal development, drug resistance, and disease. |
| Q96953571 | Sugar Phosphorylation Controls Carbon Source Utilization and Virulence of Candida albicans |
| Q35175164 | Time course global gene expression analysis of an in vivo Candida biofilm. |
Search more.